WeVote

Bill

WeVote Research Nonpartisan
Bill Summary · SB 1257

Legislative bill overview

SB 1257 requires health insurance plans in Texas to cover medical treatments for adverse effects and reversals related to gender transition procedures. The bill mandates coverage for interventions to address complications or unwanted outcomes from gender-affirming medical care, effective September 1, 2025.

Why is this important

This legislation directly affects healthcare access and insurance coverage for a specific medical population. It establishes state-level requirements for insurers regarding treatment coverage, with potential implications for insurance premiums, provider networks, and individuals seeking reversal or complication management after gender transition care.

Potential points of contention

  • Definition and scope ambiguity: The bill's language around what constitutes "adverse effects" and "reversals" may be interpreted differently, potentially leading to disputes over coverage eligibility and disputes between insurers and patients about what qualifies for mandatory coverage
  • Cost and premium impact: Mandated coverage requirements typically increase insurer costs, which may be passed to consumers through higher premiums, affecting the broader insured population
  • Medical necessity standards: Disagreement exists among medical professionals about the classification of certain treatments as medically necessary versus elective, which could create conflicts between insurers denying claims and patients seeking coverage

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.